PRTA
NASDAQ · Biotechnology
Prothena Corp Plc
$8.76
+0.18 (+2.10%)
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+54.3% upside
Low Target
$9.22
Average Target
$13.52
High Target
$14.31
Current Price
$8.76
Current
$8.76
$8.76
Target
$13.52
$13.52
$9.22
$13.52 avg
$14.31
Scenario Analysis
Bear Case
$9.22
5.3%
Low target
Base Case
$13.52
+54.3%
Avg target
Bull Case
$14.31
+63.4%
High target
Risk/Reward
12.1x
Highly favorable
Price in Context
52-Week High
$11.80
-25.8% from high
52-Week Low
$7.28
+20.3% from low
Target vs 52W High
$13.52
+14.6% vs high
Next Earnings Report
Aug 10, 2026
Today
EPS Est: $-0.40
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |